{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:25:56Z","timestamp":1781951156789,"version":"3.54.5"},"reference-count":11,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatic portal venous gas (HPVG) is a rare and potentially fatal condition. We report the case of an elderly patient with type 2 diabetes mellitus who developed HPVG. An 84-year-old woman, treated with oral hypoglycemic agents for 40 years and insulin therapy for 24 years, presented with frequent constipation due to diabetic autonomic neuropathy. She also experienced recurrent hypoglycemia resulting from blood glucose fluctuations caused by poor dietary habits. She was admitted for the management of type 2 diabetes. To prevent hypoglycemia, insulin therapy was discontinued, and treatment with dulaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), was initiated. Following the addition of acarbose, an alpha-glucosidase inhibitor (\u03b1GI), the patient developed abdominal pain and nausea. Abdominal computed tomography revealed HPVG without intestinal necrosis or signs of peritoneal irritation. Conservative therapy, along with the discontinuation of dulaglutide and acarbose, resulted in gradual improvement. We suspect that HPVG in this case was caused by dulaglutide-induced suppression of intestinal peristalsis combined with acarbose-induced elevation of intestinal pressure. To date, no cases of HPVG have been reported in patients receiving combination therapy with dulaglutide and acarbose. Clinicians should be vigilant regarding abdominal symptoms in patients receiving both GLP-1 RAs and \u03b1GIs.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag070","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:41:03Z","timestamp":1772109663000},"source":"Crossref","is-referenced-by-count":1,"title":["Hepatic portal venous gas in a patient with diabetes on GLP-1 receptor agonist and alpha-glucosidase inhibitor"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6397-9985","authenticated-orcid":false,"given":"Takaaki","family":"Noguchi","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University , Yufu City, Oita 879-5593 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Abe Diabetes Clinic , Oita City, Oita 870-0039 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Okamoto Clinic for Diabetes and Endocrinology , Bungoono City, Oita 879-7301 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koro","family":"Gotoh","sequence":"additional","affiliation":[{"name":"Research Center for Global and Local Infectious Diseases, Oita University , Yufu City, Oita 879-5593 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2378-849X","authenticated-orcid":false,"given":"Takayuki","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Practical Nursing Sciences, Faculty of Medicine, Oita University , Yufu City, Oita 879-5593 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6506-4820","authenticated-orcid":false,"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University , Yufu City, Oita 879-5593 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"3","key":"2026052007565915900_luag070-B1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000658-197803000-00012","article-title":"Hepatic\u2013portal venous gas in adults: etiology, pathophysiology and clinical significance","volume":"187","author":"Liebman","year":"1978","journal-title":"Ann Surg"},{"issue":"6","key":"2026052007565915900_luag070-B2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archsurg.2009.88","article-title":"Hepatic portal venous gas: the ABCs of management","volume":"144","author":"Nelson","year":"2009","journal-title":"Arch Surg"},{"key":"2026052007565915900_luag070-B3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2147\/IJGM.S276438","article-title":"Idiopathic hepatic portal venous gas in a healthy young man","volume":"13","author":"Kim","year":"2020","journal-title":"Int J Gen Med"},{"issue":"29","key":"2026052007565915900_luag070-B4","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.3748\/wjg.15.3585","article-title":"Hepatic portal venous gas: physiopathology, etiology, prognosis and treatment","volume":"15","author":"Abboud","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"7","key":"2026052007565915900_luag070-B5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2169\/internalmedicine.53.1789","article-title":"Do alpha-glucosidase inhibitors have the potential to induce portal venous gas? -two clinical case reports","volume":"53","author":"Makiyama","year":"2014","journal-title":"Intern Med"},{"key":"2026052007565915900_luag070-B6","doi-asserted-by":"crossref","first-page":"106237","DOI":"10.1016\/j.phrs.2022.106237","article-title":"Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment","volume":"180","author":"Lok","year":"2022","journal-title":"Pharmacol Res"},{"issue":"6","key":"2026052007565915900_luag070-B7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/jdi.12095","article-title":"Three ileus cases associated with the use of dipeptidyl peptidase-4 inhibitors in diabetic patients","volume":"4","author":"Kanasaki","year":"2013","journal-title":"J Diabetes Investig"},{"issue":"3","key":"2026052007565915900_luag070-B8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00268-017-4189-y","article-title":"In-hospital mortality for hepatic portal venous gas: analysis of 1590 patients using a Japanese national inpatient database","volume":"42","author":"Koizumi","year":"2018","journal-title":"World J Surg"},{"issue":"1","key":"2026052007565915900_luag070-B9","first-page":"279530","article-title":"Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function","volume":"2011","author":"Marathe","year":"2011","journal-title":"Exp Diabetes Res"},{"issue":"1","key":"2026052007565915900_luag070-B10","first-page":"28","article-title":"Two cases of hepatic portal venous gas in patients with type 2 diabetes during the treatment with dipeptidyl peptidase-4 inhibitors","volume":"61","author":"Higashi","year":"2018","journal-title":"J Jpn Diabetes Soc"},{"issue":"1","key":"2026052007565915900_luag070-B11","doi-asserted-by":"crossref","first-page":"e01579","DOI":"10.14309\/crj.0000000000001579","article-title":"Semaglutide-associated gastric pneumatosis","volume":"12","author":"Turunen","year":"2025","journal-title":"ACG Case Rep J"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/6\/luag070\/68214258\/luag070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/6\/luag070\/68214258\/luag070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:57:16Z","timestamp":1779278236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag070\/8667742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,4,29]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag070","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,29]]},"article-number":"luag070"}}